Study results demonstrate the performance of a specialized syringe adapter for easy, reliable and consistent administration of intradermal injections. The adapter has the potential for use with current products administered by intradermal injection, including TB vaccines and tests, rabies vaccines and flu vaccines. Dr. Hillit Shachar of West Pharmaceutical Services will discuss the following key points in her presentation:
- Dose sparing and immunogenic properties of delivery methods driving growing interest in intradermal injections
- An innovative technology that may provide an alternative to the traditional Mantoux method of intradermal injections
- The benefits of using a special adapter for intradermal injections
Presentation Details
What: “Intradermal Injections: Results of Phase I Intradermal Adapter Study”
Who: Dr. Hillit Shachar, Director, Strategic Marketing Delivery Systems, West
When: October 11, 2011 at 3:40 p.m.
Where: World Vaccine Congress, Palais de Congrès de Lyon, Lyon, France
The results will further be presented at two additional conferences. Zach Marks, Director, Strategic Marketing at West, will present the findings at the Skin Vaccination Summit, October 12-14 in Washington, D.C. as well as at the 22nd Annual RITA Conference, October 16-21 in San Juan, Puerto Rico.
About West
West’s innovative system, device and component solutions help improve the safety and administration of injectable drugs. West’s proprietary materials science, formulation research and manufacturing technologies advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics and vaccines. Sales in 2010 totaled US$1.1 billion. West supports its customers with sales, manufacturing, customer support and research and development from 50 locations in North and South America, Europe, Asia and Australia. Global headquarters are in Lionville, Pa., USA. Visit West online at www.westpharma.com. Follow West on Twitter: www.twitter.com/WestPharma
